希尔施普朗格病的治疗方法:临床病例
Viorel Țandea1,2, Ionuț Daniel Răducan3, Oana Neagu2,4
1Department of Pediatric Surgery, Grigore Alexandrescu Emergency Clinical Hospital for Children, Bucharest, Romania.
Journal of medicine and life
|September 19, 2024
概括
赫施普朗格病是一种先天性疾病,在结肠中缺乏神经细胞,导致肠道阻塞. 早期诊断和手术干预是改善受影响新生儿结果的关键.
科学领域:
- 儿科手术 儿科手术
- 胃肠病学 胃肠病学
- 发展生物学 发展生物学
背景情况:
- 赫施普朗氏病是一种先天性疾病,影响结肠的神经细胞,导致功能性肠道阻塞.
- 它大约影响5000名新生儿中的1名,主要是男性,并与慢性便秘有关.
研究的目的:
- 审查目前对希尔施普朗格病的治疗策略.
- 要突出先进的外科手术技术,诊断方法和术后管理.
- 通过临床案例来说明疾病的影响和治疗.
主要方法:
- 对希尔施普朗格病的当代治疗策略的审查.
- 分析先进的外科手术技术,诊断方法和术后护理.
- 介绍了两例临床病例,并得到了他的病理学证实.
主要成果:
- 关节段的外科切除是主要的治疗方法.
- 先进的外科手术技术和专业的术后护理可以改善结肠功能.
- 临床病例证明了成功的管理和组织病理学确认的必要性.
结论:
- 早期诊断和手术干预对于治疗赫施普朗格病至关重要.
- 综合管理,包括专门的术后护理,提高了患者的生活质量.
- 组织病理学检查仍然至关重要,以确认缺少质细胞.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
128
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
128
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
Irritable Bowel Syndrome III: Medical and Nursing Management
178
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
178
Drugs for Treatment of Diarrhea-Predominant IBS
152
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
152
Drugs for Treatment of Constipation-Predominant IBS
143
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
143


